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Antimicrobial stewardship services

NOTES

Joseph J. Carreno, Rachel M. Kenney, Mary Bloome, Jane McDonnell, Jennifer Rodriguez,
Allison Weinmann, Paul E. Kilgore, and Susan L. Davis

A

ntimicrobial resistance and the
growing scarcity of safe and effective antimicrobials have been
recognized worldwide.1 Antimicrobial stewardship programs (ASPs) have
been advocated to promote judicious
use of antimicrobials; to improve patient outcomes, safety, and resistance
patterns; and to reduce healthcare
costs. 2-6 Pharmacists with formal
infectious diseases training are often
leaders of ASPs.2,7
Unfortunately, there are not
enough specialty-trained pharmacists
to provide antimicrobial stewardship services in all healthcare settings that would benefit from these
programs.4,8 Additionally, proposed
standards for pharmacists practicing
infectious diseases pharmacotherapy
may be impractical in resourcelimited settings.8,9 Moreover, there are
numerous barriers to wider implementation of pharmacist-led ASPs.9

Purpose. Improvements in medication use
achieved by pharmacy generalists using
a care bundle approach to antimicrobial
stewardship are reported.
Methods. A six-month prospective,
repeated-treatment, quasi-experimental
study involving three month-long intervention periods and three month-long control periods was conducted in the setting of
an existing antimicrobial stewardship program at a large hospital. The intervention
involved prospective audit and feedback
conducted by pharmacy generalists who
were trained in an antimicrobial stewardship care bundle approach. During control
months, a pharmacy generalist who was
not trained in antimicrobial stewardship
rounded with the multidisciplinary team
and provided standard-of-care pharmacy
services. The primary endpoint was compliance with a care bundle of four antimicrobial stewardship metrics: documentation
of indication for therapy in the medical
record, selection of empirical therapy according to institutional guidelines, docu-
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mented performance of indicated culture
testing, and deescalation of therapy when
indicated.
Results. Two-hundred eighty-six patients
were enrolled in the study: 124 in the
intervention group and 162 in the control
group. The cumulative rate of full compliance with all care bundle components
during the six-month study was significantly greater during intervention months
than during control months (68.5% versus
45.7%, p < 0.001). After adjusting for infection type, antimicrobial stewardship provided by an intervention-group pharmacist
was associated with improved care bundle
compliance (adjusted odds ratio, 2.70; p <
0.001). No significant differences in patient
outcomes during intervention and control
months were detected.
Conclusion. Pharmacy generalists trained
to comply with a systematic care bundle
approach enhanced the quality of antimicrobial management.
Am J Health-Syst Pharm. 2015; 72:1298303
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Methods
Study design and setting. An institutional review board–approved
study was conducted at an 802bed academic, tertiary care facility. The hospital has an established
multidisciplinary ASP that uses
antimicrobial restriction and prospective audit and feedback methods focused on targeted patients
by an infectious diseases–trained
pharmacist. The research entailed
a prospective repeated-treatment
quasi-experimental study with three
observational control periods and
three intervention periods.12 Three
patient care services were observed,
with rotating pharmacist assignments. Intervention months with
an ASP-trained pharmacist were
followed by two months of control
with non-ASP-trained pharmacists;
this cycle was repeated. For each
period, the study population was
drawn from two inpatient medicine
floors and one medical intensive care
unit. The study units were selected
on the basis of the institution’s phar-

macy practice model, which provides
pharmacy services through patient
care teams. Each patient care team
is composed of clinical pharmacy
specialists, pharmacy generalists, and
pharmacy trainees. Pharmacy generalists rotate between assignments
to clinical patient care services and
drug distribution areas on a monthly
basis. The nonrandomized quasiexperimental design was selected to
coordinate with the preexisting patient care team assignments.
Inclusion and exclusion criteria.
Patients were included in the study if
they were 18 years of age or older and
were initiated on i.v. antibiotic therapy during the pharmacy generalists’
shift for an expected duration of at
least 72 hours. Patients receiving i.v.
antibiotics for prophylaxis, who had
an absolute neutrophil count (ANC)
of <1000/mm3, or were pregnant
were excluded.
Description of the intervention.
Three pharmacy generalists were
recruited to participate in a selfdirected learning module followed
by a standardized four-hour training
program designed by infectious diseases pharmacists and an infectious
diseases physician who practices in
the area of antimicrobial stewardship. The training program consisted
of national guideline and primary
literature reading assignments, with
a one-hour review session; review
of the hospital antibiogram (one
hour); and an overview of institutional guidelines for empirical and
definitive antimicrobial selection
(one hour). In addition, the pharmacists were educated on appropriate diagnostic cultures for common
infections (one hour). A reference
document listing appropriate diagnostic cultures was created through
a systematic review of institutional
and national guidelines and was approved by all coinvestigators. Finally,
the pharmacists were trained to provide prospective audit and feedback
according to an antimicrobial stewardship care bundle.5 During both

intervention and control phases of
the research, the ASP pharmacists
conducted routine audit and feedback according to ASP priorities,
which included follow-up on sterile
site cultures, restricted antimicrobials, and opportunities to switch
therapy to a narrower-spectrum
antimicrobial. Infectious diseases
consultation was available at the discretion of the primary team during
both study phases.
During the intervention periods,
the trained study pharmacists provided clinical services on the study
units. Clinical care involved the evaluation of all i.v. antimicrobial therapy using the care bundle checklist,
prospective audit, and feedback to
the primary team (delivered in person or via written communication
or by both methods) with the aim of
achieving care bundle compliance.
The care bundle consisted of four
quality indicators: (1) documentation of the indication for antibiotics
in the medical record at the time of
prescribing, (2) collection of indicated cultures, (3) empirical therapy
selection according to institutional
guidelines, and (4) a switch to a
narrower-spectrum antimicrobial
when microbiologically indicated.
The study pharmacists documented
compliance with care bundle metrics
in the electronic clinical decision
support system (Theradoc, Hospira,
Salt Lake City, UT). Care bundle
compliance was validated by the
primary investigator. During control
months, the primary investigator
documented compliance with the
care bundle, while pharmacy generalists without stewardship training
were responsible for providing the
standard of care on the study units.
The control-group pharmacy generalists did not have specific knowledge
of the study protocol. Each month a
new physician team (including different senior staff) rotated through
each individual unit, effectively resulting in a “washout” between intervention periods.
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In order to implement ASPs more
broadly, novel approaches are needed. Use of a care bundle (a checklist
of evidence-based activities) is one
potential strategy whose use was previously reported in AJHP in the context of antimicrobial stewardship.5
Another potential solution is to engage practitioners who are not infectious diseases specialists and provide
them with efficient tools to implement interventions.4,5,7 As described
in the medical literature, hospitalists
have partnered with infectious diseases physicians to enhance antimicrobial stewardship.10,11 This philosophy can also be applied to pharmacy
generalists.4 There are limited data
to demonstrate the effectiveness of
using pharmacy generalists in ASPs.
The aim of this study was to evaluate
the ability of pharmacy generalists to
enhance antimicrobial stewardship
services provided to inpatients at a
large, tertiary care hospital.

Antimicrobial stewardship services
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care bundle compliance (i.e., p <
0.2 for comparison of intervention
versus control) was analyzed using
multiple backward stepwise logistic
regression to create a model for
predicting care bundle compliance.
Statistical analysis was performed
using SPSS, version 22.0 (IBM
Corporation, Armonk, NY).
Results
A total of 721 patients were
screened for study eligibility. Reasons
for patient exclusion from enrollment were as follows: initiation of
antibiotics during nonstudy periods
(n = 228) or on nonstudy units
(n = 103), patient not expected
to receive antibiotics for at least
72 hours (n = 82), ANC value of
<1000/mm3 (n = 18), patient age of
<18 years (n = 2), and pregnancy
(n = 2). A total of 286 patients were
enrolled, 124 in the intervention
group and 162 in the control group.
Patient characteristics. Treatment and infection characteristics
were similar in the intervention and
control groups (Table 1). The most
common sites of infection were
the lower respiratory tract (n = 79,
27.6%) and the genitourinary tract
(n = 60, 20.9%); 52 patients (18.2%)

Table 1.

Baseline Data on Patients in Study Populationa
Variable
Median (IQR) age, yr
Male sex, no. (%)
Median (IQR) creatinine
clearance, mL/minb
Mean (IQR) Charlson
Comorbidity Index score
Hospital unit, no. (%)
General practice unit 1
General practice unit 2
Medical intensive care unit
Insured, no. (%)

Intervention
Group (n = 124)

Control Group
(n = 162)

p

65 (53–73)
64 (52)

62 (51–75)
75 (46)

0.60
0.37

38 (15–72)

46 (21–74)

0.26

3 (2–4)

2 (2–4)

0.29

36 (29)
35 (28)
53 (43)
118 (95)

42 (26)
73 (45)
47 (29)
148 (91)

0.01c

0.21

IQR = interquartile range.
Estimated via Cockcroft–Gault equation.
Calculated using chi-square test for 3 × 2 table comparison of general practice units 1 and 2 and the medical
intensive care unit in the intervention and control groups.
a

b
c
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had two or more suspected sites
of infection. The most commonly
utilized antimicrobials were vancomycin (n = 177, 61.9%), cefepime
(n = 160, 55.9%), third-generation
cephalosporins (n = 129, 45.1%),
metronidazole (n = 106, 37.1%),
and macrolides (n = 49, 17.1%).
Care bundle compliance. Data on
compliance with the care bundle over
the six study months are graphically
depicted in Figure 1. Compliance
with all care bundle metrics was
significantly higher during intervention months than during control
months (85 of 124 patients [68.5%]
versus 74 of 162 patients [45.7%],
p < 0.001). Separate analyses of the
four metrics showed that documentation of indication for therapy occurred significantly more often in
the intervention group than in the
control group (122 of 124 patients
[98.4%] versus 151 of 162 patients
[93.2%], p = 0.04), as did selection of
empirical therapy in accordance with
institutional guidelines (112 of 124
patients [90.3%] versus 115 of 162
patients [71.0%], p < 0.001); there
was no significant difference between
the intervention and control groups
with regard to collection of indicated
cultures (106 of 124 patients [85.5%]
and 128 of 162 patients [79.0%], respectively; p = 0.16) or the proportion of patients who were switched to
a narrower-spectrum antimicrobial
(40 of 49 patients [81.6%] versus 49
of 61 patients [80.3%], p = 0.86).
Antimicrobial utilization. The
median antimicrobial length of therapy was similar in the intervention
group (6 days; interquartile range
[IQR], 4–9 days) and the control group
(6 days; IQR, 4–8 days; p = 0.29). The
total length of therapy was 758 days
per 1000 patient-days in the control
group, compared with 689 days per
1000 patient-days in the intervention group. Values for total days of
therapy per 1000 patient-days were
1463 per 1000 in the control group
and 1367 per 1000 in the intervention group, respectively (statistical
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Endpoints. The primary outcome
was compliance with the care bundle
of four antimicrobial stewardship
process metrics described earlier.5,13
Secondary outcomes included compliance with the individual components of the care bundle; and
resource utilization markers, including length of therapy per 1000
patient-days, days of therapy per 1000
patient-days, inhospital mortality,
30-day mortality, and infectionrelated readmission within 30 days.
Sample size calculation. Based
on previous literature estimates,5 a
sample size of at least 85 patients per
group was needed to detect a 20%
difference between study groups with
5% alpha and 80% power.
Data analysis. All data were collected using a standardized form.
Categorical data were analyzed
using two-sided chi-square tests.
Continuous parametric data were
analyzed using a two-sided Student’s
t test, and nonparametric data were
analyzed via a two-sided Mann–
Whitney U test where appropriate.
Multivariable regression was performed to identify independent predictors of care bundle compliance.
Any variable with a clinical rationale
that was found to be associated with

NOTES

infection-related readmission within
30 days (12.1% versus 8%, p = 0.251).
Discussion
In our study, pharmacy generalists
who received standardized training
significantly improved the quality of
antibiotic management (as measured
by care bundle compliance) relative
to routine pharmacy services. In a
previous study at the same study site,
Toth and colleagues5 demonstrated
an increase in compliance with care
bundle metrics (from 16% to 54%)
through the use of the same care
bundle approach. DiazGranados and
Abd4 also recently explored expanded
use of ASPs with pharmacy generalists. In their study, they suggested
that antimicrobial stewardship responsibilities can be performed by
pharmacy generalists under the
supervision of an infectious diseases
physician. The results of our study
add support for that suggestion.
The study data presented here
further justify the role of pharmacy
generalists in performing antimicrobial stewardship, as well as the utility
of a stewardship care bundle, by pro-

viding reproducibility (i.e., data were
collected on three separate but parallel inpatient units through multiple
observations).
The study had several notable limitations, including potential volunteer
bias. Also, the study measurements excluded antimicrobial therapy initiated
outside of the pharmacist’s clinical
daytime shift so that only the direct
impact of the intervention pharmacist
was evaluated. Expanding this intervention to other pharmacy shifts could
improve effectiveness but may be impractical, as there may not be enough
qualified pharmacists to oversee all
shifts. Two out of the three pharmacy
generalists involved in the study were
graduates of ASHP-accredited residencies, and the third had practiced
for approximately 20 years before participation in the study; however, none
of these pharmacists met proposed
standards for pharmacists practicing in the area of infectious diseases
pharmacotherapy.8
A quasi-experimental study design
was used, and such methodology is
subject to several limitations, including the potential for unaccounted

Figure 1. Compliance with the antimicrobial stewardship care bundle at the study site during designated intervention months (blue)
and control months (green), as determined by the percentage of study patients whose antimicrobial therapy was in compliance with
all care bundle components.
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analyses were not performed due to
the small number of observation periods [i.e., three per group]).
Factors associated with care bundle compliance. Data on associations
of evaluated variables and care bundle compliance are presented in Table
2. Patients with bloodstream infections were significantly more likely to
receive treatment involving complete
care bundle compliance than those
without bloodstream infections
(unadjusted odds ratio [OR], 2.61;
p = 0.03). With adjustment for the
presence of abdominal or lower respiratory tract infections, patients in
the intervention group were significantly more likely than those in the
control group to receive care bundle–
compliant antimicrobial therapy
(adjusted OR, 2.70; p < 0.001). No
other variables tested were significantly associated with care bundle
compliance. No significant differences were identified in patient outcomes between the intervention and
control groups with regard to inhospital mortality (4.8% versus 7.4%,
p = 0.375), 30-day mortality (9.7%
versus 9.9%, p = 0.955), or rates of
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uses multiple strategies advocated
in national guidelines. While data
collected in this setting may not be
generalizable to all hospitals, we
hypothesize that care bundle compliance benefits even greater than those
reported here might be observed in
settings that have clinical pharmacy
services but lack a formal ASP.
Of interest, we observed an overall
enhancement of the existing ASP
with pharmacy generalist intervention, particularly with regard to
improving the quality of empirical
therapy selection and documentation of indications for antibiotics
in the medical record. We speculate
that these improvements related to
the presence of a pharmacy generalist on the primary team (i.e., the
pharmacist was well positioned to
intervene at the time of prescribing
and medical record documentation).
The ASP currently operates with one
antimicrobial stewardship pharmacist full-time equivalent providing
audit and feedback throughout the

802-bed hospital. The ASP pharmacist prioritizes sterile-site infection
management and antibiotic deescalation. Accordingly, we observed in the
bivariable analysis that patients with
a bloodstream infection were more
likely to be managed in compliance
with the care bundle and that deescalation was performed in approximately 80% of both intervention and
control patients.
The study results add to the literature demonstrating that a care
bundle approach may facilitate more
effective utilization of limited resources.3,14-16 Care bundles have been
used effectively in the prevention of
ventilator-associated pneumonia,14
in the resuscitation and management
of patients with sepsis,15 and in the
management of Staphylococcus aureus bacteremia16 and candidemia.3
These promising findings lend support for future research on the implementation of antimicrobial stewardship care bundles and their impact
on outcomes of infection.

Table 2.

Association of Evaluated Patient Variables With Care Bundle Compliance, by Analytical Methoda
Bivariable Regression

Multivariable Regression

Variable

OR (95% CI)

p

Adjusted ORb (95% CI)

p

Enrollment in intervention group
Age
Female
Insured
Admitted to ICU at baseline
Charlson Comorbidity Index score
Infection sitec
Abdominal
Bloodstreamd
Bone
Central nervous system
Genitourinary tract
I.V. catheter
Lower respiratory tract
Skin and soft tissue
Upper respiratory tract
Wound

2.59 (1.59–4.23)
0.99 (0.98–1.01)
0.77 (0.70–1.96)
0.82 (0.33–2.08)
1.10 (0.68–1.82)
0.95 (0.85–1.05)

<0.001
0.23
0.55
0.26
0.68
0.30

2.70 (1.64–4.46)
Not tested
Not tested
Not tested
Not tested
Not tested

<0.001

0.66 (0.37–1.18)
2.61 (1.07–6.35)
0.47 (0.11–2.00)
1.20 (0.20–7.31)
1.36 (0.82–2.55)
2.19 (0.57–8.43)
0.72 (0.45–1.18)
1.29 (0.66–2.55)
1.20 (0.20–7.31)
0.80 (0.11–5.73)

0.16
0.03
0.47
1.00
0.23
0.36
0.19
0.45
1.00
0.82

0.59 (0.31–1.11)
2.24 (0.89–5.59)
Not tested
Not tested
Not tested
Not tested
0.62 (0.37–1.05)
Not tested
Not tested
Not tested

0.10
0.09

OR = odds ratio, CI = confidence interval, ICU = intensive care unit.
Goodness of fit Nagelkerke R2 = 0.11.
C
Infection sites were not mutually exclusive and were analyzed separately.
d
Includes both secondary and primary bacteremia or fungemia.
a

b
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confounders. To minimize this source
of bias, we attempted to identify the
most important confounders a priori
and used regression techniques to
identify independent predictors of
care bundle compliance. Regression
to the mean (and maturation) are
also potential threats to the validity
of the study findings.12 In our study,
control group compliance with the
care bundle was 46%; in the aforementioned prior study at the same
study site, a 16% compliance rate
was observed.5 This improvement in
the baseline level of compliance over
time suggests that prescribers at the
institution may be maturing in their
antimicrobial management practices.
However, maturation and regression
to the mean do not appear to account
for the differences observed through
monthly observations during our
six-month repeated treatment study
(Figure 1).
Finally with regard to limitations,
our study was conducted in the
setting of an established ASP that

NOTES

Conclusion
Pharmacy generalists trained to
comply with a systematic care bundle
approach enhanced the quality of
antimicrobial management.
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